PX'Therapeutics–Thermo Fisher: mass spectrometer, 201009 supply existent OrbiTrap Discovery at Promise Advanced Proteomics

	Period	2010-09-14
	Region	Grenoble
	Country	France
	Partner, 1st	Promise Advanced Proteomics
	Group	PX’Therapeutics (Group)
	Partner, 2nd	Thermo Fisher Scientific (Bremen) GmbH
	Group	Thermo Fisher (Group)
	Product	LTQ Orbitrap Discovery™ mass spectrometer
	Product 2	PSAQ™ method (Protein Standard for Absolute Quantification)

Promise Advanced Proteomics. (9/14/10). "Corporate Information by E-Mail".

A spokesperson for Promise Advanced Proteomics responded to [iito] Business Intelligence that Promise is a 51% subsidiary of PX'Therapeutics. Promise licensed its patented PSAQ method from CEA, which also holds an interest in the company.

Promise Advanced Proteomics uses a QTrap4000 (AB SCIEX) to analyse biologcial samples containing the PSAQ standard. For quality control of the PSAQ an Orbitrap (Thermo Scientific) is used. Routinely this is an OrbiTrap XL, but the company also has an OrbiTrap Discovery. The QTrap4000 is also used to control the incorporation of labelled amino acids.

Record changed: 2011-11-25

Follow Us!

Top News

Upcoming Events

Associations

Partners

PX'Therapeutics–Thermo Fisher: mass spectrometer, 201009 supply existent OrbiTrap Discovery at Promise Advanced Proteomics

Promise Advanced Proteomics. (9/14/10). "Corporate Information by E-Mail".

More documents for PX’Therapeutics (Group)